文献速递心境障碍

拆解、优化与个性化抑郁症网络认知行为治疗:基于个体参与者数据的系统综述与成分网络Meta分析

Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data.
PubMed 文献 · Lancet Psychiatry · 2021-05-03

28项为聚合数据,共6474人)进行成分网络Meta分析,评估抑郁症网络认知行为治疗(iCBT)中各成分的效果。基线严重度是终点抑郁的最强预后因素;

要点

  • 基线抑郁严重度是预测终点抑郁的最强预后因素。

核心结论

  • 个体参与者数据成分网络Meta分析揭示了iCBT方案中可能有益、效果较差或有害的成分及交付形式。
  • 旨在高效有效的iCBT方案可选择纳入有益成分并排除潜在有害成分。
  • 基于网络应用可促进治疗师与患者共同决策选择偏好的iCBT方案。

研究设计与样本

  • 系统综述与个体参与者数据成分网络Meta分析,检索PubMed、PsycINFO、Embase和Cochrane Library从建库至2019年1月1日的随机对照试验。
  • 纳入比较任何形式iCBT与另一形式或对照条件急性期治疗成人(≥18岁)抑郁症的随机对照试验,排除住院患者或双相抑郁患者。
  • 主要结局为抑郁严重度,以患者健康问卷-9(PHQ-9)评分中成分加入治疗时的增量平均差(iMD)表示。

主要发现

  • 基线严重度是终点抑郁的最强预后因素。
  • 多数纳入研究的随机化过程、缺失结局数据或报告结果选择偏倚风险低,偏离预期干预风险不确定,结局测量风险高;研究及其成分间存在中高度异质性。

临床怎么用

  • 选择iCBT方案时可优先纳入行为激活成分,避免或谨慎使用放松训练成分。
  • 根据患者基线抑郁严重度进行预后评估和个性化方案选择。
  • 结合人类与自动化鼓励以提高治疗依从性、减少脱落。
  • 可利用网络应用估算不同成分组合的相对疗效,辅助治疗师与患者共同决策。

局限性

  • 研究间及其成分存在中高度异质性。
  • 结局测量偏倚风险高,偏离预期干预风险不确定。
  • 部分试验仅使用聚合数据而非个体参与者数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Internet cognitive behavioural therapy (iCBT) is a viable delivery format of CBT for depression. However, iCBT programmes include training in a wide array of cognitive and behavioural skills via different delivery methods, and it remains unclear which of these components are more efficacious and for whom. METHODS: We did a systematic review and individual participant data component network meta-analysis (cNMA) of iCBT trials for depression. We searched PubMed, PsycINFO, Embase, and the Cochrane Library for randomised controlled trials (RCTs) published from database inception to Jan 1, 2019, that compared any form of iCBT against another or a control condition in the acute treatment of adults (aged ≥18 years) with depression. Studies with inpatients or patients with bipolar depression were excluded. We sought individual participant data from the original authors. When these data were unavailable, we used aggregate data. Two independent researchers identified the included components. The primary outcome was depression severity, expressed as incremental mean difference (iMD) in the Patient Health Questionnaire-9 (PHQ-9) scores when a component is added to a treatment. We developed a web app that estimates relative efficacies between any two combinations of components, given baseline patient characteristics. This study is registered in PROSPERO, CRD42018104683. FINDINGS: We identified 76 RCTs, including 48 trials contributing individual participant data (11 704 participants) and 28 trials with aggregate data (6474 participants). The participants' weighted mean age was 42·0 years and 12 406 (71%) of 17 521 reported were women. There was suggestive evidence that behavioural activation might be beneficial (iMD -1·83 [95% credible interval (CrI) -2·90 to -0·80]) and that relaxation might be harmful (1·20 [95% CrI 0·17 to 2·27]). Baseline severity emerged as the strongest prognostic factor for endpoint depression. Combining human and automated encouragement reduced dropouts from treatment (incremental odds ratio, 0·32 [95% CrI 0·13 to 0·93]). The risk of bias was low for the randomisation process, missing outcome data, or selection of reported results in most of the included studies, uncertain for deviation from intended interventions, and high for measurement of outcomes. There was moderate to high heterogeneity among the studies and their components. INTERPRETATION: The individual patient data cNMA revealed potentially helpful, less helpful, or harmful components and delivery formats for iCBT packages. iCBT packages aiming to be effective and efficient might choose to include beneficial components and exclude ones that are potentially detrimental. Our web app can facilitate shared decision making by therapist and patient in choosing their preferred iCBT package. FUNDING: Japan Society for the Promotion of Science.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Furukawa TA, Suganuma A, Ostinelli EG, et al. Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data. Lancet Psychiatry. 2021. PMID: 33957075. doi:10.1016/S2215-0366(21)00077-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。